6.3 USD
-0.11 (-1.72%)
6.28 USD
-0.02 (-0.32%)
LFST gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 101 industry peers in the Health Care Providers & Services industry. While LFST seems to be doing ok healthwise, there are quite some concerns on its profitability. While showing a medium growth rate, LFST is valued expensive at the moment.
1. Profitability
1.1 Basic Checks
LFST had negative earnings in the past year.
LFST had a positive operating cash flow in the past year.
In the past 5 years LFST always reported negative net income.
The reported operating cash flow has been mixed in the past 5 years: LFST reported negative operating cash flow in multiple years.
1.2 Ratios
LFST has a Return On Assets (-0.42%) which is in line with its industry peers.
LFST's Return On Equity of -0.61% is in line compared to the rest of the industry. LFST outperforms 54.46% of its industry peers.
With a Return On Invested Capital value of 0.29%, LFST is not doing good in the industry: 61.39% of the companies in the same industry are doing better.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -0.42% | ||
| ROE | -0.61% | ||
| ROIC | 0.29% |
ROA(3y)-7.15%
ROA(5y)-11.83%
ROE(3y)-10.4%
ROE(5y)-16.72%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
LFST has a Operating Margin of 0.52%. This is in the lower half of the industry: LFST underperforms 60.40% of its industry peers.
LFST does not have Profit Margin and Gross Margin available, so we won't be analyzing them here.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 0.52% | ||
| PM (TTM) | N/A | ||
| GM | N/A |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), LFST is destroying value.
The number of shares outstanding for LFST has been increased compared to 1 year ago.
The number of shares outstanding for LFST has been increased compared to 5 years ago.
The debt/assets ratio for LFST is higher compared to a year ago.
2.2 Solvency
LFST has an Altman-Z score of 2.47. This is not the best score and indicates that LFST is in the grey zone with still only limited risk for bankruptcy at the moment.
LFST has a Altman-Z score (2.47) which is in line with its industry peers.
LFST has a debt to FCF ratio of 2.36. This is a good value and a sign of high solvency as LFST would need 2.36 years to pay back of all of its debts.
LFST has a better Debt to FCF ratio (2.36) than 79.21% of its industry peers.
LFST has a Debt/Equity ratio of 0.18. This is a healthy value indicating a solid balance between debt and equity.
The Debt to Equity ratio of LFST (0.18) is better than 70.30% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.18 | ||
| Debt/FCF | 2.36 | ||
| Altman-Z | 2.47 |
ROIC/WACC0.03
WACC8.92%
2.3 Liquidity
A Current Ratio of 1.58 indicates that LFST should not have too much problems paying its short term obligations.
LFST has a Current ratio of 1.58. This is comparable to the rest of the industry: LFST outperforms 59.41% of its industry peers.
A Quick Ratio of 1.58 indicates that LFST should not have too much problems paying its short term obligations.
LFST has a Quick ratio of 1.58. This is in the better half of the industry: LFST outperforms 62.38% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.58 | ||
| Quick Ratio | 1.58 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 88.46% over the past year.
Looking at the last year, LFST shows a quite strong growth in Revenue. The Revenue has grown by 13.39% in the last year.
The Revenue has been growing by 42.55% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)88.46%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%100%
Revenue 1Y (TTM)13.39%
Revenue growth 3Y23.29%
Revenue growth 5Y42.55%
Sales Q2Q%16.34%
3.2 Future
Based on estimates for the next years, LFST will show a very strong growth in Earnings Per Share. The EPS will grow by 46.80% on average per year.
The Revenue is expected to grow by 13.96% on average over the next years. This is quite good.
EPS Next Y80.88%
EPS Next 2Y50.17%
EPS Next 3Y46.8%
EPS Next 5YN/A
Revenue Next Year14.25%
Revenue Next 2Y14.19%
Revenue Next 3Y14.5%
Revenue Next 5Y13.96%
3.3 Evolution
Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
4. Valuation
4.1 Price/Earnings Ratio
LFST reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Based on the Price/Forward Earnings ratio of 154.41, the valuation of LFST can be described as expensive.
LFST's Price/Forward Earnings ratio is a bit more expensive when compared to the industry. LFST is more expensive than 64.36% of the companies in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 36.22, LFST is valued quite expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | 154.41 |
4.2 Price Multiples
Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of LFST is on the same level as its industry peers.
LFST's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. LFST is cheaper than 63.37% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 20.53 | ||
| EV/EBITDA | 40.75 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
LFST's earnings are expected to grow with 46.80% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y50.17%
EPS Next 3Y46.8%
5. Dividend
5.1 Amount
LFST does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
6.3
-0.11 (-1.72%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners38%
Inst Owner Change1.17%
Ins Owners3%
Ins Owner Change-8.88%
Market Cap2.45B
Revenue(TTM)1.37B
Net Income(TTM)-9.12M
Analysts84.29
Price Target8.74 (38.73%)
Short Float %3.88%
Short Ratio3.42
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)83.66%
Min EPS beat(2)67.32%
Max EPS beat(2)100%
EPS beat(4)4
Avg EPS beat(4)77.82%
Min EPS beat(4)43.98%
Max EPS beat(4)100%
EPS beat(8)7
Avg EPS beat(8)50.21%
EPS beat(12)9
Avg EPS beat(12)22.07%
EPS beat(16)10
Avg EPS beat(16)12.4%
Revenue beat(2)1
Avg Revenue beat(2)-0.82%
Min Revenue beat(2)-1.93%
Max Revenue beat(2)0.3%
Revenue beat(4)2
Avg Revenue beat(4)-0.46%
Min Revenue beat(4)-1.94%
Max Revenue beat(4)1.72%
Revenue beat(8)4
Avg Revenue beat(8)0.27%
Revenue beat(12)7
Avg Revenue beat(12)0.6%
Revenue beat(16)8
Avg Revenue beat(16)-0.1%
PT rev (1m)1.69%
PT rev (3m)1.69%
EPS NQ rev (1m)-99.4%
EPS NQ rev (3m)-233.2%
EPS NY rev (1m)0%
EPS NY rev (3m)-26.32%
Revenue NQ rev (1m)-0.47%
Revenue NQ rev (3m)-0.22%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.07%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | 154.41 | ||
| P/S | 1.79 | ||
| P/FCF | 20.53 | ||
| P/OCF | 16.24 | ||
| P/B | 1.64 | ||
| P/tB | 131.46 | ||
| EV/EBITDA | 40.75 |
EPS(TTM)-0.03
EYN/A
EPS(NY)0.04
Fwd EY0.65%
FCF(TTM)0.31
FCFY4.87%
OCF(TTM)0.39
OCFY6.16%
SpS3.52
BVpS3.84
TBVpS0.05
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -0.42% | ||
| ROE | -0.61% | ||
| ROCE | 0.37% | ||
| ROIC | 0.29% | ||
| ROICexc | 0.33% | ||
| ROICexgc | 2.32% | ||
| OM | 0.52% | ||
| PM (TTM) | N/A | ||
| GM | N/A | ||
| FCFM | 8.73% |
ROA(3y)-7.15%
ROA(5y)-11.83%
ROE(3y)-10.4%
ROE(5y)-16.72%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score7
Asset Turnover0.64
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.18 | ||
| Debt/FCF | 2.36 | ||
| Debt/EBITDA | 4.27 | ||
| Cap/Depr | 56.29% | ||
| Cap/Sales | 2.3% | ||
| Interest Coverage | 0.37 | ||
| Cash Conversion | 239.11% | ||
| Profit Quality | N/A | ||
| Current Ratio | 1.58 | ||
| Quick Ratio | 1.58 | ||
| Altman-Z | 2.47 |
F-Score7
WACC8.92%
ROIC/WACC0.03
Cap/Depr(3y)65.1%
Cap/Depr(5y)98.49%
Cap/Sales(3y)4.93%
Cap/Sales(5y)7.81%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)88.46%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%100%
EPS Next Y80.88%
EPS Next 2Y50.17%
EPS Next 3Y46.8%
EPS Next 5YN/A
Revenue 1Y (TTM)13.39%
Revenue growth 3Y23.29%
Revenue growth 5Y42.55%
Sales Q2Q%16.34%
Revenue Next Year14.25%
Revenue Next 2Y14.19%
Revenue Next 3Y14.5%
Revenue Next 5Y13.96%
EBIT growth 1Y111.08%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year441.48%
EBIT Next 3Y95.15%
EBIT Next 5Y67.21%
FCF growth 1Y420.43%
FCF growth 3YN/A
FCF growth 5Y99.09%
OCF growth 1Y6636.92%
OCF growth 3Y124.97%
OCF growth 5Y44.46%
LIFESTANCE HEALTH GROUP INC / LFST FAQ
What is the fundamental rating for LFST stock?
ChartMill assigns a fundamental rating of 3 / 10 to LFST.
What is the valuation status of LIFESTANCE HEALTH GROUP INC (LFST) stock?
ChartMill assigns a valuation rating of 2 / 10 to LIFESTANCE HEALTH GROUP INC (LFST). This can be considered as Overvalued.
What is the profitability of LFST stock?
LIFESTANCE HEALTH GROUP INC (LFST) has a profitability rating of 1 / 10.